凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002821 凯莱英

已收盘 12-19 15:00:00

{"stockData":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":94.79,"timestamp":1766127813000,"preClose":91.03,"halted":0,"volume":6587010,"delay":0,"changeRate":0.0413,"floatShares":317000000,"shares":361000000,"eps":2.881,"marketStatus":"已收盘","change":3.76,"latestTime":"12-19 15:00:00","open":91.19,"high":95.6,"low":90.7,"amount":620000000,"amplitude":0.0538,"askPrice":94.8,"askSize":87,"bidPrice":94.79,"bidSize":51,"shortable":0,"etf":0,"ttmEps":2.881,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766367000000},"marketStatusCode":5,"adr":0,"adjPreClose":91.03,"symbolType":"stock","openAndCloseTimeList":[[1766107800000,1766115000000],[1766120400000,1766127600000]],"highLimit":100.13,"lowLimit":81.93,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":360593720,"isCdr":false,"pbRate":1.89,"roa":"--","peRate":32.90177,"roe":"4.63%","epsLYR":2.69,"committee":0.013333,"marketValue":34181000000,"turnoverRate":0.0208,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-12-22。","hkstockBrief":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":80,"timestamp":1766131686007,"preClose":72.45,"halted":0,"volume":458220,"delay":0,"premium":"-23.74"},"floatMarketCap":30048000000},"requestUrl":"/m/hq/s/002821","defaultTab":"news","newsList":[{"id":"2592167370","title":"凯莱英(06821)将购回及注销3.3万股受限制A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2592167370","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592167370?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:30","pubTimestamp":1766151039,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，于2025年12月19日，本公司董事会审议并通过《关于回购注销2025年A股计划部分限制性股票的议案》，将购回及注销3.3万股由7名已离职合资格参与者根据2025年A股计划首次授予，以及一名已离职合资格参与者根据2025年A股计划预留授予项下所持有的已授出但尚未解禁的受限制A股股份(购回及注销事项)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383989.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159982","399300","BK0239","002821","LU1328615791.USD","BK0132","BK1191","06821"],"gpt_icon":0},{"id":"2592345351","title":"医药股今早显著反弹 凯莱英及药明生物均涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592345351","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592345351?lang=zh_cn&edition=full","pubTime":"2025-12-19 11:05","pubTimestamp":1766113500,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　医药股今早明显反弹，CRO、创新药方向居前。截至发稿，凯莱英（06821）上涨6.07%，报76.85港元；药明生物（02269）上涨6.05%，报34.70港元；三生制药（01530）上涨4.65%，报26.58港元；诺诚健华（09969）上涨4.70%，报13.80港元。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-12-19/doc-inhcicep7752391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B0JY6N72.USD","159938","LU0417516738.SGD","LU0572944931.SGD","LU0327786744.USD","LU0039217434.USD","LU0051755006.USD","LU1794554557.SGD","BK1589","LU0320764599.SGD","LU0516423174.USD","LU0043850808.USD","LU0979878070.USD","BK1515","BK1574","LU0516423091.SGD","LU0348735423.USD","LU0823426480.USD","BK1161","06821","BK1141","09939","LU0181495838.USD","LU0516422366.SGD","LU0417516902.SGD","LU0708995583.HKD","BK1521","002821","LU0856984785.SGD","LU3063872942.SGD","BK0239","02269","LU0359201612.USD","LU0588546209.SGD","LU0456846285.SGD","BK1576","LU0823426308.USD","LU0359202008.SGD","SG9999002463.SGD","LU1328615791.USD","LU1242518857.USD","LU0456827905.SGD","LU0052750758.USD","BK1610","LU1688375341.USD","LU0516422952.EUR","LU1720050803.USD","SG9999002562.SGD","LU0140636845.USD","LU0819121731.USD"],"gpt_icon":0},{"id":"2589383288","title":"港股异动 | 凯莱英(06821)午前涨近3% 近期凯莱英生物上海奉贤基地正式投产 重点布局联药物NDCs等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2589383288","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589383288?lang=zh_cn&edition=full","pubTime":"2025-12-08 11:34","pubTimestamp":1765164854,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凯莱英午前涨近3%，截至发稿，涨2.05%，报79.65港元，成交额1551.75万港元。消息面上，近期，据凯莱英官微消息，公司旗下凯莱英生物的上海奉贤商业化生产基地正式投产，该基地是凯莱英生物继上海金山基地和张江科学技术中心后重点打造的又一核心商业化产业基地，可助力客户快速推进商业化生产。奉贤基地商业化投产意味着凯莱英生物在生物药CDMO领域实现跨越式升级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","LU1328615791.USD","BK1191","06821","BK0132","BK0239"],"gpt_icon":0},{"id":"2588028059","title":"凯莱英（002821）披露A股股权激励股份转让进展，12月2日股价下跌2.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588028059","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588028059?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:24","pubTimestamp":1764685492,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，凯莱英报收于92.6元，较前一交易日下跌2.06%，最新总市值为333.91亿元。公司近日发布公告称，截至2025年11月30日的证券变动月报表显示，凯莱英A股已发行股份增加291,400股，库存股相应减少291,400股，变动原因为2025年A股股权激励计划项下的库存股份转让。H股和A股的法定/注册股本均无变动，H股限制性股票计划下可能转让的股份为1,465,000股，H股库存股数量未发生变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200039861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","06821","399300","159982","BK0132","LU1328615791.USD","BK1191","BK0239"],"gpt_icon":0},{"id":"2586455247","title":"凯莱英(06821)授出29.14万股A股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2586455247","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586455247?lang=zh_cn&edition=full","pubTime":"2025-11-27 19:29","pubTimestamp":1764242989,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，于2025年11月27日授出29.14万股A股限制性股票。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["159982","LU1328615791.USD","002821","BK0239","BK0132","BK1191","399300","06821"],"gpt_icon":0},{"id":"2586107212","title":"凯莱英：持续技术创新保障业务增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2586107212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586107212?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:15","pubTimestamp":1764231322,"startTime":"0","endTime":"0","summary":"证券之星消息，凯莱英11月27日在投资者关系平台上答复投资者关心的问题。作为一家在创立伊始就将“技术驱动”作为企业核心竞争力的公司，凯莱英一贯重视技术创新和研发投入，持续保持对前沿技术的积极投入、探索与应用是保持CDMO产业稳健发展的关键。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700019630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","002821","BK0132","LU1328615791.USD","BK0239","06821"],"gpt_icon":0},{"id":"2584936667","title":"摩根大通减持凯莱英(06821)7.07万股 每股作价约84.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584936667","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584936667?lang=zh_cn&edition=full","pubTime":"2025-11-18 18:42","pubTimestamp":1763462572,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，11月12日，摩根大通减持凯莱英(06821)7.07万股，每股作价84.704港元，总金额约为598.86万港元。减持后最新持股数目约为188.79万股，最新持股比例为6.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370619.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2211815571.USD","IE00BKDWB100.SGD","IE0034235303.USD","IE00BDRTCR15.USD","LU2746668461.USD","IE00BZ1G4Q59.USD","BK4504","BK4566","IE00BLSP4239.USD","LU2264538146.SGD","LU1629891620.HKD","LU0882574139.USD","LU2357305700.SGD","LU1548497426.USD","BK4516","IE00BJTD4V19.USD","LU1974910355.USD","LU0868494708.USD","LU0787776722.HKD","BK4585","IE0034235188.USD","LU2023250330.USD","IE00BLSP4452.SGD","06821","002821","LU0310799852.SGD","IE00BDCRKT87.USD","LU1551013425.SGD","LU1366192091.USD","LU0048584097.USD","LU0211327993.USD","IE00BWXC8680.SGD","LU0211331839.USD","LU2237443895.HKD","LU0689472784.USD","LU1280957306.USD","LU1670627923.USD","BK0132","LU0251132253.USD","LU0234572021.USD","LU0211326755.USD","LU2236285917.USD","IE000M9KFDE8.USD","LU0820561909.HKD","LU2756315664.SGD","LU2023250504.SGD","LU0976567544.SGD","BK4534","IE00B3S45H60.SGD","BK4533"],"gpt_icon":0},{"id":"2583556496","title":"摩根大通增持凯莱英(06821)6.19万股 每股均价约83.89港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583556496","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583556496?lang=zh_cn&edition=full","pubTime":"2025-11-13 18:58","pubTimestamp":1763031493,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，11月10日，摩根大通增持凯莱英(06821)6.19万股，每股均价83.8905港元，总金额约为519.28万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20251113/20251113185845_63494.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251113/20251113185845_63494.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU2211815571.USD","IE0034235303.USD","LU2237443549.SGD","IE00BDRTCR15.USD","LU1032466523.USD","LU0070302665.USD","LU0496365809.HKD","LU2462157665.USD","LU2357305700.SGD","LU0211328371.USD","LU1119994496.HKD","LU2213496289.HKD","BK4516","LU1974910355.USD","LU1116320737.USD","LU0964807845.USD","LU2237443382.USD","LU0265550359.USD","BK0239","LU0868494708.USD","LU1162221912.USD","BK4585","LU0256863811.USD","LU1894683348.USD","06821","002821","BK4534","LU0310799852.SGD","LU0868494617.USD","LU1244550494.USD","LU1366192091.USD","IE00BYXW3230.USD","LU0048584097.USD","LU2054465674.USD","LU2237443895.HKD","LU0215105999.USD","LU0689472784.USD","LU2417539215.USD","LU1280957306.USD","LU0323591593.USD","LU0640476718.USD","LU2237443622.USD","LU0820561909.HKD","LU0238689110.USD","LU2023250504.SGD","LU2237443978.SGD","LU0976567544.SGD","IE00B1XK9C88.USD","LU1670628061.USD","BK4533"],"gpt_icon":0},{"id":"2582500363","title":"Norges Bank增持凯莱英(06821)6.52万股 每股作价约84.39港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582500363","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582500363?lang=zh_cn&edition=full","pubTime":"2025-11-11 18:51","pubTimestamp":1762858283,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，11月7日，Norges Bank增持凯莱英(06821)6.52万股，每股作价84.3896港元，总金额约为550.22万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20251111/20251111185210_91310.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251111/20251111185210_91310.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1191","BK0239","LU1328615791.USD","06821","BK0132","002821"],"gpt_icon":0},{"id":"2582118248","title":"凯莱英遭摩根大通减持20.2万股 每股作价约83.43港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582118248","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582118248?lang=zh_cn&edition=full","pubTime":"2025-11-10 07:49","pubTimestamp":1762732140,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，11月4日，摩根大通减持凯莱英（06821）20.2万股，每股作价83.432港元，总金额约为1685.33万港元。减持后最新持股数目约为204.32万股，持股比例为7.41%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-11-10/doc-infwwmew9382427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2211815571.USD","IE0034235303.USD","BK4207","BK4581","IE00BDRTCR15.USD","LU2746668461.USD","LU2456880835.USD","BK4504","LU2264538146.SGD","LU0345769631.USD","IE0034235295.USD","BK4516","LU2505996681.GBP","LU2237443382.USD","LU1162221912.USD","LU1496350171.SGD","06821","002821","BK4534","LU2430703095.HKD","IE00BDCRKT87.USD","LU2430703251.USD","LU0203347892.USD","LU1551013425.SGD","LU1366192091.USD","IE00BYXW3230.USD","LU0345770993.USD","LU0211327993.USD","LU0683600562.USD","LU0170899867.USD","LU0320765489.SGD","LU2106854487.HKD","LU0345769128.USD","LU0943347566.SGD","LU1280957306.USD","LU1988902786.USD","LU2023250843.SGD","LU2430703178.SGD","SG9999002224.SGD","BK4588","LU0234572021.USD","IE00B775SV38.USD","SG9999002232.USD","LU2236285917.USD","LU1668664300.SGD","LU2592432038.USD","IE00B1XK9C88.USD","LU2417539215.USD","IE00B1BXHZ80.USD","BK4533"],"gpt_icon":0},{"id":"2581004638","title":"摩根大通减持凯莱英(06821)20.2万股 每股作价约83.43港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581004638","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581004638?lang=zh_cn&edition=full","pubTime":"2025-11-07 19:37","pubTimestamp":1762515427,"startTime":"0","endTime":"0","summary":"11月4日，摩根大通减持凯莱英(06821)20.2万股，每股作价83.432港元，总金额约为1685.33万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20251107/20251107193130_99273.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251107/20251107193130_99273.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06821","IE00B775SV38.USD","IE00BBT3K403.USD","LU2430703095.HKD","LU0251132253.USD","LU0868494617.USD","LU0882574139.USD","LU1917777945.USD","BK0239","LU1244550221.USD","LU1244550494.USD","LU0964807845.USD","IE00BZ1G4Q59.USD","BK4534","LU0265550946.USD","LU2430703178.SGD","LU1363072403.SGD","LU2417539215.USD","LU1551013425.SGD","SG9999002224.SGD","IE00BYXW3230.USD","LU1328615791.USD","BK1191","LU1720051017.SGD","LU2746668974.SGD","LU1629891620.HKD","LU0417517546.SGD","LU0070302665.USD","002821","LU2430703251.USD","LU0106261372.USD","LU1670628061.USD","LU2462157665.USD","BK4533","LU2237443382.USD","LU0320765489.SGD","LU2211815571.USD","LU2746668461.USD","SG9999002232.USD","LU1974910355.USD","LU0211328371.USD","LU0971096721.USD","LU0211327993.USD","BK4581","LU2213496289.HKD","LU2242649171.HKD","LU0149725797.USD","LU2756315318.SGD","LU2023250330.USD","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2581026740","title":"港股异动 | 凯莱英(06821)涨超3% 前三季度归母净利同比增加12.66% 新兴业务有望成为核心增长引擎","url":"https://stock-news.laohu8.com/highlight/detail?id=2581026740","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581026740?lang=zh_cn&edition=full","pubTime":"2025-11-07 10:43","pubTimestamp":1762483400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凯莱英涨超3%，截至发稿，涨3.12%，报85.8港元，成交额1368.32万港元。消息面上，近日，凯莱英发布公告，于2025年前三季度，该集团取得营业收入46.3亿元，同比增加11.82%；归属于上市公司股东的净利润8亿元，同比增加12.66%；基本每股收益2.18元。新兴业务增长强劲，2025年前三季度新兴业务收入同比增长71.9%，毛利率为30.6%，其中化学大分子业务收入同比增长超150%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002821","BK0132","06821","LU1328615791.USD","BK1191"],"gpt_icon":0},{"id":"2581246066","title":"Norges Bank增持凯莱英(06821)6.23万股 每股作价约84.51港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581246066","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581246066?lang=zh_cn&edition=full","pubTime":"2025-11-06 19:15","pubTimestamp":1762427723,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，11月3日，Norges Bank增持凯莱英(06821)6.23万股，每股作价84.5083港元，总金额约为526.49万港元。增持后最新持股数目为388.83万股，持股比例为14.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","BK1191","BK0132","002821","LU1328615791.USD","BK0239"],"gpt_icon":0},{"id":"2581785937","title":"摩根大通增持凯莱英(06821)15.58万股 每股作价约82.76港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581785937","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581785937?lang=zh_cn&edition=full","pubTime":"2025-11-05 19:00","pubTimestamp":1762340439,"startTime":"0","endTime":"0","summary":"智通财经获悉，香港联交所最新资料显示，10月31日，摩根大通增持凯莱英(06821)15.58万股，每股作价82.7632港元，总金额约1289.45万港元。增持后最新持股数目约为232.68万股，最新持股比例为8.44%。\n\n港股频道更多独家策划、专家专栏，免费查阅>>\n\r\n            责任编辑：山上","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2025/11/05190054033897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1551013425.SGD","LU2213496289.HKD","LU1244550221.USD","LU2462157665.USD","LU2237443549.SGD","LU2746668974.SGD","LU0211327993.USD","LU0211328371.USD","LU2237443622.USD","BK4516","LU0251132253.USD","LU0149725797.USD","SG9999002232.USD","BK4533","IE00BYXW3230.USD","LU2023250330.USD","LU2211815571.USD","LU0868494617.USD","LU2237443895.HKD","BK0239","LU2417539215.USD","IE00BLSP4452.SGD","LU0971096721.USD","LU2756315318.SGD","06821","LU2430703178.SGD","LU1244550494.USD","LU2242649171.HKD","LU0265550946.USD","002821","LU0417517546.SGD","LU2237443382.USD","LU1917777945.USD","LU1894683348.USD","LU0320765489.SGD","LU1720051017.SGD","LU0882574139.USD","BK1191","LU1328615791.USD","LU0496365809.HKD","LU0964807845.USD","BK4581","LU1363072403.SGD","LU1670628061.USD","LU2430703251.USD","IE00BZ1G4Q59.USD","BK4534","LU0070302665.USD","LU1974910355.USD","SG9999002224.SGD"],"gpt_icon":0},{"id":"2581132749","title":"凯莱英：天津小分子业务产能紧张需扩充","url":"https://stock-news.laohu8.com/highlight/detail?id=2581132749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581132749?lang=zh_cn&edition=full","pubTime":"2025-11-05 16:24","pubTimestamp":1762331064,"startTime":"0","endTime":"0","summary":"证券之星消息，凯莱英(002821)11月05日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司吉林敦化小分子反应釜产能并不饱满，为何还准备在天津扩建API产能？是为了满足天津市的投资要求吗？凯莱英回复：尊敬的投资者，您好！公司所服务众多客户多个小分子API项目年内陆续获批上市，以及未来小分子临床后期项目向后快速推进，目前天津小分子业务产能处于紧张状态，为满足公司业务发展需扩充新的API产能。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500027170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","06821","BK0132","002821","BK0239","LU1328615791.USD"],"gpt_icon":0},{"id":"2581450117","title":"凯莱英：医药外包服务渗透率仍在提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2581450117","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581450117?lang=zh_cn&edition=full","pubTime":"2025-11-05 15:51","pubTimestamp":1762329076,"startTime":"0","endTime":"0","summary":"证券之星消息，凯莱英(002821)11月05日在投资者关系平台上答复投资者关心的问题。投资者提问：美国大客户商业化销售出现波动，是药物不需要我们生产了吗？凯莱英回复：尊敬的投资者，您好！国际制药行业专业化分工趋势未发生改变，医药外包服务渗透率仍在提升。个别客户小分子药物研发管线调整或商业化阶段产品销售收入短期波动不会改变行业格局。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500023876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","06821","BK0132","BK1515","002821","BK1574","BK1161","LU1328615791.USD","BK0239","09939","BK1191"],"gpt_icon":0},{"id":"2580273033","title":"凯莱英：小分子业务受客户管线调整影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2580273033","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580273033?lang=zh_cn&edition=full","pubTime":"2025-11-04 09:12","pubTimestamp":1762218742,"startTime":"0","endTime":"0","summary":"作为一个投资者，对公司 的股价在牛市中严重落于板块感到非常的失望、凯莱英回复：尊敬的投资者，您好！上述情况主要受公司美国市场部分大制药公司客户的的小分子药物管线业务调整影响，其研发管线调整及商业化药物销售在今年出现了波动。后续伴随这部分客户小分子药物业务调整完成，以及公司其他客户小分子药物管线销售放量，公司小分子业务收入将重新进入良性增长轨道。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400006872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","06821","002821","LU1328615791.USD","BK0239","BK1191"],"gpt_icon":0},{"id":"2580291303","title":"Schroders PLC减持凯莱英(06821)2.81万股 每股作价约86.16港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580291303","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580291303?lang=zh_cn&edition=full","pubTime":"2025-11-03 19:05","pubTimestamp":1762167944,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，10月30日，Schroders PLC减持凯莱英(06821)2.81万股，每股作价86.1644港元，总金额约为242.12万港元。减持后最新持股数目为604.58万股，最新持股比例为21.94%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","BK0132","06821","LU1328615791.USD","BK1191","BK0239"],"gpt_icon":0},{"id":"2580291305","title":"Norges Bank增持凯莱英(06821)21.37万股 每股作价约86.6港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580291305","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580291305?lang=zh_cn&edition=full","pubTime":"2025-11-03 18:59","pubTimestamp":1762167585,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，10月30日，Norges Bank增持凯莱英(06821)21.37万股，每股作价86.6001港元，总金额约为1850.64万港元。增持后最新持股数目为372.22万股，持股比例为13.51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0132","LU1328615791.USD","06821","BK0239","002821"],"gpt_icon":0},{"id":"2580298593","title":"凯莱英：前三季度新兴业务收入同比增长71.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580298593","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580298593?lang=zh_cn&edition=full","pubTime":"2025-11-03 17:21","pubTimestamp":1762161672,"startTime":"0","endTime":"0","summary":"证券之星消息，凯莱英11月03日在投资者关系平台上答复投资者关心的问题。公司前三季度新兴业务收入同比增长71.87%，其中化学大分子业务收入同比增长超150%。第三季度公司新签订单保持双位数增长，并相较于上半年增速有所提升，其中新业务板块中的化学大分子业务、生物大分子业务新签订单均保持强劲增长势头。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300023392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0132","BK0239","06821","LU1328615791.USD","002821"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766245006327,"stockEarnings":[{"period":"1week","weight":0.0075},{"period":"1month","weight":0.0347},{"period":"3month","weight":-0.1437},{"period":"6month","weight":0.1597},{"period":"1year","weight":0.2285},{"period":"ytd","weight":0.2619}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":-0.0143},{"period":"3month","weight":0.0184},{"period":"6month","weight":0.1579},{"period":"1year","weight":0.1544},{"period":"ytd","weight":0.1607}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"凯莱英医药集团(天津)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2016-11-18","address":"天津市滨海新区经济技术开发区洞庭三街6号","registeredCapital":"36059万元","survey":"　　凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是临床阶段CDMO解决方案、商业化阶段CDMO解决方案、新兴服务。截至报告期末公司共有国内外已授权专利538项，其中国内专利423项，国外专利115项，其中183项在合成生物领域，204项在连续反应技术领域。","listedPrice":30.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,002821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}